Skip to main navigation Skip to search Skip to main content

Rare clinical manifestations in systemic lupus erythematosus: a review on frequency and clinical presentation

  • Chiara Tani
  • , Elena Elefante
  • , Laurant Arnaud
  • , Sofia Barreira
  • , Inita Bulina
  • , Lorenzo Cavagna
  • , Nathalie Costedoat-Chalumeau
  • , Andrea Doria
  • , Joao Fonseca
  • , Franco Franceschini
  • , Micaela Fredi
  • , Luca Iaccarino
  • , Maarten Limper
  • , Judit Majnik
  • , Gyorgy Nagy
  • , Christina Pamfil
  • , Simona Rednic
  • , John Reynolds
  • , Maria Tektonidou
  • , Anne Troldborg
  • Giovanni Zanframundo, Marta Mosca

Research output: Contribution to journalReview articlepeer-review

Abstract

OBJECTIVES: The purpose of this study was to review the frequency and clinical presentation of the rarest clinical manifestations of systemic lupus erythematosus (SLE).

METHODS: A list of 6 rare SLE manifestations were defined: gastrointestinal, liver, pulmonary, cardiac, ocular and neurological manifestations. Each topic was assigned to a pair of authors to perform a literature search and article review.

RESULTS: In total, 149 articles were included in the literature review: 37 for gastrointestinal manifestations, 6 for liver manifestations, 27 for pulmonary manifestations, 50 for cardiac manifestations, 16 for ocular manifestations, 13 for neurological manifestations. Gastrointestinal disorders included several clinical presentations with variable frequency (from 0.5% to 10.7% of the cases); liver involvement included lupus-related hepatitis (9.3%) and autoimmune hepatitis (2.3%). The rarest pulmonary manifestations identified were shrinking lung syndrome, described in 1.5% of patients, while interstitial lung disease and lupus pneumonia were reported in 4% and 3% of patients respectively. Myocarditis and pulmonary hypertension were also rarely described in SLE patients although ranging from 0.4-16% and 1-14% respectively, depending on the methodology used for its identification. Ocular manifestations in SLE included some rare manifestations (reported in less than 5% of patients) and lupus retinopathy that is described in 1.2-28.8% of patients depending on methods of ascertainment. Aseptic meningitis and chorea were also confirmed as very rare manifestations being reported in less than 1% and in 0.3-2.4% of cases respectively.

CONCLUSIONS: The results of this literature review provide the basis for a better understanding of some less-known manifestations of SLE and for stressing the need for a higher awareness in diagnostic and therapeutic protocols regarding these rare disease aspects.
Original languageEnglish
Pages (from-to)S93-S102
Number of pages10
JournalClinical and Experimental Rheumatology
Volume40
Issue number5, Suppl 134
DOIs
Publication statusPublished - 18 May 2022

Bibliographical note

Funding Information:
Funding and disclaimer: page S99. Competing interests: L. Arnaud has acted as a consultant for Alexion, Amgen, Astra-Zeneca, Abbvie, Biogen, BMS, Boehringer-Ingelheim, Cemka, GSK, Grifols, Janssen-Cilag, Kezar, LFB, Lilly, Medac, Novartis, Oséus, Pfizer, Roche-Chugai, Semeia, UCB. I. Bulina has received honoraria from Abbvie, Boehringer-Ingelheim, Janssen and Pfizer. N. Costedoat-Chalumeau has received grants from UCB for a clinical research study. The other authors have declared no competing interests.

Publisher Copyright:
© Copyright Clinical and Experimental Rheumatology 2022.

Fingerprint

Dive into the research topics of 'Rare clinical manifestations in systemic lupus erythematosus: a review on frequency and clinical presentation'. Together they form a unique fingerprint.

Cite this